{"pmid":32499057,"title":"Prescribing parenteral nutrition in acute hospital setting during COVID-19: The Singapore experience.","text":["Prescribing parenteral nutrition in acute hospital setting during COVID-19: The Singapore experience.","Clin Nutr","Salazar, Ennaliza","Cheah, Mark C C","32499057"],"journal":"Clin Nutr","authors":["Salazar, Ennaliza","Cheah, Mark C C"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499057","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.clnu.2020.05.029","locations":["Singapore"],"countries":["Singapore"],"countries_codes":["SGP|Singapore"],"topics":["Prevention"],"weight":1,"_version_":1668804508790030336,"score":9.490897,"similar":[{"pmid":32253375,"pmcid":"PMC7135971","title":"Nutritional management in hospital setting during SARS-CoV-2 pandemic: a real-life experience.","text":["Nutritional management in hospital setting during SARS-CoV-2 pandemic: a real-life experience.","Eur J Clin Nutr","Cintoni, Marco","Rinninella, Emanuele","Annetta, Maria Giuseppina","Mele, Maria Cristina","32253375"],"journal":"Eur J Clin Nutr","authors":["Cintoni, Marco","Rinninella, Emanuele","Annetta, Maria Giuseppina","Mele, Maria Cristina"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32253375","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1038/s41430-020-0625-4","topics":["Prevention"],"weight":1,"_version_":1666138493151084544,"score":55.93911},{"pmid":32487434,"title":"Considerations for the management of home parenteral nutrition during the SARS-CoV-2 pandemic: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.","text":["Considerations for the management of home parenteral nutrition during the SARS-CoV-2 pandemic: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.","The management of patients with chronic intestinal failure requiring home parenteral nutrition has been and will continue to be impaired during the SARS-CoV-2 pandemic. Multidisciplinary intestinal failure teams may have to adapt their clinical approaches to home care, outpatient care as well as hospital admission and discharge in order to keep this vulnerable group of patients as safe and well as possible during the unprecedented challenges that countries are facing during the pandemic. Equally, it is important that expert advice from intestinal failure teams is available when home parenteral nutrition (HPN)-dependent patients require admission with SARS-CoV-2 infection. The Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of the European Society for Clinical Nutrition and Metabolism (ESPEN) has developed a position paper to outline areas for intestinal failure teams to consider when managing patients with chronic intestinal failure during the SARS-CoV-2 pandemic.","Clin Nutr","Lal, Simon","Van Gossum, Andre","Joly, Francisca","Bozzetti, Federico","Cuerda, Cristina","Lamprecht, Georg","Mundi, Manpreet S","Staun, Michael","Szczepanek, Kinga","Wanten, Geert","Wheatley, Carolyn","Pironi, Loris","32487434"],"abstract":["The management of patients with chronic intestinal failure requiring home parenteral nutrition has been and will continue to be impaired during the SARS-CoV-2 pandemic. Multidisciplinary intestinal failure teams may have to adapt their clinical approaches to home care, outpatient care as well as hospital admission and discharge in order to keep this vulnerable group of patients as safe and well as possible during the unprecedented challenges that countries are facing during the pandemic. Equally, it is important that expert advice from intestinal failure teams is available when home parenteral nutrition (HPN)-dependent patients require admission with SARS-CoV-2 infection. The Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of the European Society for Clinical Nutrition and Metabolism (ESPEN) has developed a position paper to outline areas for intestinal failure teams to consider when managing patients with chronic intestinal failure during the SARS-CoV-2 pandemic."],"journal":"Clin Nutr","authors":["Lal, Simon","Van Gossum, Andre","Joly, Francisca","Bozzetti, Federico","Cuerda, Cristina","Lamprecht, Georg","Mundi, Manpreet S","Staun, Michael","Szczepanek, Kinga","Wanten, Geert","Wheatley, Carolyn","Pironi, Loris"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487434","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.clnu.2020.05.023","keywords":["chronic intestinal failure","coronavirus","home parenteral nutrition"],"topics":["Prevention"],"weight":1,"_version_":1668623433666134018,"score":49.353775},{"pmid":32297089,"pmcid":"PMC7157827","title":"Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients.","text":["Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients.","The development of COVID-19 syndrome in anticoagulated patients, and especially their admission to intensive-care units with acute severe respiratory syndrome (SARS-CoV-2), expose them to specific problems related to their therapy, in addition to those associated with the acute viral infection. Patients on VKA hospitalized with SARS-CoV-2 show high instability of PT INR due to the variability of vitamin K metabolism, diet, fasting, co-medications, liver impairment, and heart failure. Patients on DOAC are exposed to under/over treatment caused by significant pharmacological interferences. In consideration of the pharmacological characteristics of oral anticoagulant drugs, the multiple pharmacological interactions due to the treatment of acute disease and the possible necessity of mechanical ventilation with hospitalization in intensive-care units, we suggest replacing oral anticoagulant therapies (VKA and DOAC) with parenteral heparin to avoid the risk of over/under treatment.","Intern Emerg Med","Testa, Sophie","Paoletti, Oriana","Giorgi-Pierfranceschi, Matteo","Pan, Angelo","32297089"],"abstract":["The development of COVID-19 syndrome in anticoagulated patients, and especially their admission to intensive-care units with acute severe respiratory syndrome (SARS-CoV-2), expose them to specific problems related to their therapy, in addition to those associated with the acute viral infection. Patients on VKA hospitalized with SARS-CoV-2 show high instability of PT INR due to the variability of vitamin K metabolism, diet, fasting, co-medications, liver impairment, and heart failure. Patients on DOAC are exposed to under/over treatment caused by significant pharmacological interferences. In consideration of the pharmacological characteristics of oral anticoagulant drugs, the multiple pharmacological interactions due to the treatment of acute disease and the possible necessity of mechanical ventilation with hospitalization in intensive-care units, we suggest replacing oral anticoagulant therapies (VKA and DOAC) with parenteral heparin to avoid the risk of over/under treatment."],"journal":"Intern Emerg Med","authors":["Testa, Sophie","Paoletti, Oriana","Giorgi-Pierfranceschi, Matteo","Pan, Angelo"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297089","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s11739-020-02331-1","keywords":["covid-19","doac","lmwh","sars-cov-2","vka"],"e_drugs":["Vitamin K","Heparin"],"topics":["Treatment"],"weight":1,"_version_":1666138493291593728,"score":42.822174},{"pmid":32405110,"pmcid":"PMC7219411","title":"Prescribing COVID-19 treatments: what we should never forget.","text":["Prescribing COVID-19 treatments: what we should never forget.","J Infect","Tunesi, S","Bourgarit, A","32405110"],"journal":"J Infect","authors":["Tunesi, S","Bourgarit, A"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405110","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jinf.2020.05.018","topics":["Treatment"],"weight":1,"_version_":1666950579784515584,"score":41.4895},{"pmid":32379029,"title":"Understanding the Singapore COVID-19 Experience: Implications for Hospital Medicine.","text":["Understanding the Singapore COVID-19 Experience: Implications for Hospital Medicine.","J Hosp Med","Vidyarthi, Arpana R","Bagdasarian, Natasha","Esmaili, Armond M","Archuleta, Sophia","Monash, Bradley","Sehgal, Niraj L","Green, Adrienne","Lim, Aymeric","32379029"],"journal":"J Hosp Med","authors":["Vidyarthi, Arpana R","Bagdasarian, Natasha","Esmaili, Armond M","Archuleta, Sophia","Monash, Bradley","Sehgal, Niraj L","Green, Adrienne","Lim, Aymeric"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379029","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12788/jhm.3436","locations":["Singapore"],"countries":["Singapore"],"countries_codes":["SGP|Singapore"],"topics":["Prevention"],"weight":1,"_version_":1666597097404628993,"score":41.428802}]}